Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
Clinical trial NCT03573050 · COMPLETED
Trial details
- NCT number
- NCT03573050
- Sponsor
- SocraTec R&D GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2018-07-05
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.